These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12589395)

  • 1. Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders.
    Marek GJ; Carpenter LL; McDougle CJ; Price LH
    Neuropsychopharmacology; 2003 Feb; 28(2):402-12. PubMed ID: 12589395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine.
    Marek GJ; Martin-Ruiz R; Abo A; Artigas F
    Neuropsychopharmacology; 2005 Dec; 30(12):2205-15. PubMed ID: 15886717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions.
    Tarazi FI; Zhang K; Baldessarini RJ
    Psychopharmacology (Berl); 2002 May; 161(3):263-70. PubMed ID: 12021829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
    Ichikawa J; Ishii H; Bonaccorso S; Fowler WL; O'Laughlin IA; Meltzer HY
    J Neurochem; 2001 Mar; 76(5):1521-31. PubMed ID: 11238736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain.
    Moreau X; Jeanningros R; Mazzola-Pomietto P
    Neuropsychopharmacology; 2001 Jun; 24(6):652-62. PubMed ID: 11331145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT2A antagonists in psychiatric disorders.
    de Angelis L
    Curr Opin Investig Drugs; 2002 Jan; 3(1):106-12. PubMed ID: 12054060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of serotonin receptor subtypes in treating depression: a review of animal studies.
    Carr GV; Lucki I
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):265-87. PubMed ID: 21107537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects.
    Sotty F; Folgering JH; Brennum LT; Hogg S; Mørk A; Hertel P; Cremers TI
    Neuropharmacology; 2009 Jul; 57(1):18-24. PubMed ID: 19376075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of rapid-onset antidepressant treatment strategies.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
    Millan MJ; Veiga S; Girardon S; Brocco M
    Psychopharmacology (Berl); 2003 Aug; 168(4):397-409. PubMed ID: 12721776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors.
    McMahon LR; Cunningham KA
    Neuropsychopharmacology; 2001 Mar; 24(3):319-29. PubMed ID: 11166521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Kuroki T; Dai J; Meltzer HY
    Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT).
    Fox MA; Stein AR; French HT; Murphy DL
    Br J Pharmacol; 2010 Feb; 159(4):879-87. PubMed ID: 20128812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice.
    Monaca C; Boutrel B; Hen R; Hamon M; Adrien J
    Neuropsychopharmacology; 2003 May; 28(5):850-6. PubMed ID: 12637954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo.
    Yadav PN; Kroeze WK; Farrell MS; Roth BL
    J Pharmacol Exp Ther; 2011 Oct; 339(1):99-105. PubMed ID: 21737536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of 5-HT(1A) and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition.
    El Mansari M; Blier P
    J Psychiatry Neurosci; 2005 Jul; 30(4):268-74. PubMed ID: 16049570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.
    Celada P; Puig M; Amargós-Bosch M; Adell A; Artigas F
    J Psychiatry Neurosci; 2004 Jul; 29(4):252-65. PubMed ID: 15309042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of serotonin receptors in the action of atypical antipsychotic drugs.
    Meltzer HY; Massey BW
    Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirtazapine abolishes hyperthermia in an animal model of serotonin syndrome.
    Shioda K; Nisijima K; Yoshino T; Kato S
    Neurosci Lett; 2010 Oct; 482(3):216-9. PubMed ID: 20655983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in 5-HT1B/1D receptor antagonists and agonists and their potential therapeutic applications.
    Slassi A
    Curr Top Med Chem; 2002 Jun; 2(6):559-74. PubMed ID: 12052194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.